Flight From Risk Drives Biotech Stocks to Worst Start Since 2016

Flight From Risk Drives Biotech Stocks to Worst Start Since 2016

(Bloomberg) -- Stocks from just about every corner of the health-care industry have been beaten back this month as investors retreat from risk. But few have been hit as hard as biotechnology.

Most Read from Bloomberg

Boeing Is Set to Launch Its First New Jet in Nearly Five Years With 50-Plane Qatar Deal